Table 1.

Patient and tumor characteristics.

Female12
Male8
Age18–62, average 41
Performance status
 0/1/212/7/1
Primary site
 Stomach (gastroesophageal)16 (1)
 Small bowel2
 Peritoneum1
Metastatic sites
 Liver17
 Peritoneum11
 Lymph nodes4
Prior therapies1–7, median 3
Biomarker (N samples)N (%) with biomarker
 SDHA deficient (17)6 (35)
 SDHB deficient (17)15 (88)
 IGF-1R High (14)10 (71)
 pAKT High (14)6 (43)